AMED Archives - Market Exclusive

Home Tags AMED

Amedisys Inc (NASDAQ:AMED) had its Hold rating reiterated by Craig Hallum...

ME Staff - March 1, 2019

Amedisys Inc (NASDAQ:AMED) price target raised to $145.00 by SunTrust Banks

ME Staff - March 1, 2019

Amedisys Inc (NASDAQ:AMED) gets downgraded to Hold by Benchmark with a...

ME Staff - February 5, 2019

Amedisys Inc (NASDAQ:AMED) gets downgraded to Hold by Benchmark

ME Staff - February 5, 2019

Amedisys, Inc. (NASDAQ:AMED) Files An 8-K Entry into a Material Definitive...

ME Staff 8-k - February 4, 2019

Amedisys Inc (NASDAQ:AMED) has coverage initiated with a Equal Weight ➝...

ME Staff - December 14, 2018

Amedisys Inc (NASDAQ:AMED) has coverage initiated with a Equal Weight rating

ME Staff - December 14, 2018

Amedisys Inc (NASDAQ:AMED) gets upgraded to Buy by Benchmark with a...

ME Staff - October 30, 2018

Amedisys Inc (NASDAQ:AMED) gets downgraded to Hold by Craig Hallum with...

ME Staff - October 26, 2018

Amedisys Inc (NASDAQ:AMED) price target raised to $130.00 by SunTrust Banks

ME Staff - October 11, 2018

12 3...5 Page 1 of 5

/* */

EDITOR PICKS

Cannabis Stock News Daily Roundup April 12

April 12, 2019

Market Morning: Alexa Spying, Boeing Sensor History, Macron Spoils Scallop Dinner

April 11, 2019

ICC, AgraFlora to Bring Native Colombian Cannabis Strains to 39K Retail...

April 10, 2019

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: AMED